1,539
Views
28
CrossRef citations to date
0
Altmetric
Special Issue: Measuring HIV Associated Mortality in Africa

How have ART treatment programmes changed the patterns of excess mortality in people living with HIV? Estimates from four countries in East and Southern Africa

, , , , , , , , & show all
Article: 22789 | Received 09 Sep 2013, Accepted 11 Mar 2014, Published online: 22 Apr 2014

References

  • Todd J, Balira R, Grosskurth H, Mayaud P, Mosha F, ka-Gina G, etal. HIV-associated adult mortality in a rural Tanzanian population. AIDS. 1997; 11: 801–7.
  • Nunn AJ, Mulder DW, Kamali A, Ruberantwari A, Kengeya-Kayondo JF, Whitworth J. Mortality associated with HIV-1 infection over five years in a rural Ugandan population: cohort study. BMJ. 1997; 315: 767–71.
  • Sewankambo NK, Wawer MJ, Gray RH, Serwadda D, Li C, Stallings RY, etal. Demographic impact of HIV infection in rural Rakai District, Uganda: results of a population-based cohort study. AIDS. 1994; 8: 1707–14.
  • Nyirenda M, Hosegood V, Barnighausen T, Newell ML. Mortality levels and trends by HIV serostatus in rural South Africa. AIDS. 2007; 21(Suppl 6): S73–9.
  • Marston M, Todd J, Glynn JR, Nelson KE, Rangsin R, Lutalo T, etal. Estimating ‘net’ HIV-related mortality and the importance of background mortality rates. AIDS. 2007; 21(Suppl 6): S65–71.
  • Kasamba I, Baisley K, Mayanja BN, Maher D, Grosskurth H. The impact of antiretroviral treatment on mortality trends of HIV-positive adults in rural Uganda: a longitudinal population-based study, 1999–2009. Trop Med Int Health. 2012; 17: e66–73.
  • Marston M, Michael D, Wringe A, Isingo R, Clark BD, Jonas A, etal. The impact of antiretroviral therapy on adult mortality in rural Tanzania. Trop Med Int Health. 2012; 17: e58–65.
  • Gargano JW, Laserson K, Muttai H, Odhiambo F, Orimba V, Adamu-Zeh M, etal. The adult population impact of HIV care and antiretroviral therapy in a resource poor setting, 2003–2008. AIDS. 2012; 26(12): 1545–54.
  • Floyd S, Marston M, Baisley K, Wringe A, Herbst K, Chihana M, etal. The effect of antiretroviral therapy provision on all-cause, AIDS and non-AIDS mortality at the population level – a comparative analysis of data from four settings in Southern and East Africa. Trop Med Int Health. 2012; 17: e84–93.
  • Reniers G, Araya T, Davey G, Nagelkerke N, Berhane Y, Coutinho R, etal. Steep declines in population-level AIDS mortality following the introduction of antiretroviral therapy in Addis Ababa, Ethiopia. AIDS. 2009; 23: 511–18.
  • The Antiretroviral Therapy in Lower Income Countries (ART-LINC) Collaboration, ART Cohort Collaboration (ART-CC) groups. Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. Lancet. 2006; 367: 817–24.
  • Wringe A, Floyd S, Kazooba P, Mushati P, Baisley K, Urassa M, etal. Antiretroviral therapy uptake and coverage in four HIV community cohort studies in sub-Saharan Africa. Trop Med Int Health. 2012; 17: e38–48.
  • Lawn SD, Harries AD, Wood R. Strategies to reduce early morbidity and mortality in adults receiving antiretroviral therapy in resource-limited settings. Curr Opin HIV AIDS. 2010; 5: 18–26.
  • Masiira B, Baisley K, Mayanja BN, Kazooba P, Maher D, Kaleebu P. Mortality and its predictors among antiretroviral therapy naive HIV-infected individuals with CD4 cell count ≥350 cells/mm (3) compared to the general population: data from a population-based prospective HIV cohort in Uganda. Glob Health Action. 2014; 7: 21843.
  • Michael D, Kanjala C, Calvert C, Pretorius C, Wringe A, Todd J, etal. Does the Spectrum model accurately predict trends in adult mortality? Evaluation of model estimates using empirical data from a rural HIV community cohort study in North-Western Tanzania. Glob Health Action. 2014; 7: 21783.
  • Nabukalu D, Klipstein-Grobusch K, Herbst K, Newell ML. Mortality in women of reproductive age in rural South Africa. Glob Health Action. 2013; 6: 22834.
  • Tenu F, Isingo R, Zaba B, Urassa M, Todd J. Adjusting the HIV prevalence for non-respondents using mortality rates in an open cohort in northwest Tanzania. Tropical Medicine & International Health. 2014
  • Crampin AC, Dube A, Mboma S, Price A, Chihana M, Jahn A, etal. Profile: the Karonga Health and Demographic Surveillance System. Int J Epidemiol. 2012; 41: 676–85.
  • Tanser F, Hosegood V, Barnighausen T, Herbst K, Nyirenda M, Muhwava W, etal. Cohort profile: Africa Centre Demographic Information System (ACDIS) and population-based HIV survey. Int J Epidemiol. 2008; 37: 956–62.
  • Bärnighausen T, Tanser F, Malaza A, Herbst K, Newell ML. HIV status and participation in HIV surveillance in the era of antiretroviral treatment: a study of linked population-based and clinical data in rural South Africa. Trop Med Int Health. 2012; 17: e103–10.
  • Urassa M, Boerma JT, Isingo R, Ngalula J, Ng'weshemi J, Mwaluko G, etal. The impact of HIV/AIDS on mortality and household mobility in rural Tanzania. AIDS. 2001; 15: 2017–23.
  • Mbulaiteye S, Mahe C, Ruberantwari A, Whitworth J. Generalizability of population-based studies on AIDS: a comparison of newly and continuously surveyed villages in rural southwest Uganda. Int J Epidemiol. 2002; 31: 961–7.
  • Crampin AC, Glynn JR, Fine PE. What has Karonga taught us? Tuberculosis studied over three decades. Int J Tuberc Lung Dis. 2009; 13: 153–64.
  • Sewankambo NK, Gray RH, Ahmad S, Serwadda D, Wabwire-Mangen F, Nalugoda F, etal. Mortality associated with HIV infection in rural Rakai District, Uganda. AIDS. 2000; 14: 2391–400.
  • Chihana M, Floyd S, Molesworth A, Crampin AC, Kayuni N, Price A, etal. Adult mortality and probable cause of death in rural northern Malawi in the era of HIV treatment. Trop Med Int Health. 2012; 17: e74–83.
  • Rodger AJ, Lodwick R, Schechter M, Deeks S, Amin J, Gilson R, etal. Mortality in well controlled HIV in the continuous antiretroviral therapy arms of the SMART and ESPRIT trials compared with the general population. AIDS. 2013; 27: 973–9.
  • The Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord. Lewden C, Bouteloup V, De Wit S, Sabin C, Mocroft A, etal. All-cause mortality in treated HIV-infected adults with CD4 ≥500/mm3 compared with the general population: evidence from a large European observational cohort collaboration. Int J Epidemiol. 2012; 41: 433–45.
  • Brinkhof MWG, Boulle A, Weigel R, Messou E, Mathers C, Orrell C, etal. Mortality of HIV-infected patients starting antiretroviral therapy in sub-Saharan Africa: comparison with HIV-unrelated mortality. PLoS Med. 2009; 6: e1000066.
  • The Antiretroviral Therapy Cohort Collaboration. Causes of death in HIV-1–infected patients treated with antiretroviral therapy, 1996–2006: collaborative analysis of 13 HIV cohort studies. Clin Infect Dis. 2010; 50: 1387–96.
  • The Antiretroviral Therapy Cohort Collaboration. Mortality of HIV-infected patients starting potent antiretroviral therapy: comparison with the general population in nine industrialized countries. Int J Epidemiol. 2009; 38: 1624–33.
  • Hosegood V, Vanneste A-M, Timæus IM. Levels and causes of adult mortality in rural South Africa: the impact of AIDS. AIDS. 2004; 18: 663–71.
  • Ortblad KF, Lozano R, Murray CJL. The burden of HIV: insights from the GBD 2010. AIDS. 2013; 27: 2003–17.